A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and ...

NCCN—an alliance of leading cancer centers—publishes a new resource to inform people about the latest recommendations around ...

During the international meeting, experts from across the region will present new and updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®): MENA Editions, and selected topics ...

"The inclusion of ctDNA testing in the NCCN Guidelines brings Foresight closer to our mission of improving the lives of cancer patients worldwide by delivering innovative diagnostics that provide ...

During a Case-Based Roundtable® event, Nakhle Saba, MD, and participants discussed treatment for a patient with chronic ...

胰腺癌是一种发病率持续攀升的侵袭性全身性疾病，预计到2030年将成为癌症相关死亡的第二大常见原因。胰腺癌的预后普遍较差，相关诊疗指南中标准诊疗路径和标准治疗方案的更新一直为广大临床医生所关注。近期，美国国家综合癌症网络（NCCN）更新了胰腺癌2025 ...

Christina Henson, MD, discussed some of the current imaging guidelines in head and neck cancer, with a focus on extranodal ...

Ongoing commercial launch of AUCATZYL® on track, with 24 treatment centers fully authorized as of January 10th- National Comprehensive Cancer ...

Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology, today announced the inclusion of circulating tumor DNA (ctDNA) testing in the National ...

During the international meeting, experts from across the region will present new and updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): MENA Editions, and selected topics ...

Free information from the National Comprehensive Cancer Network offers information on how and why to access genetic counseling and testing for multiple hereditary cancers The new NCCN Guidelines ...